There are several anti-obesity drugs in the pipeline that work through similar mechanisms that should be entering the market which should lower the price throug

There are several anti-obesity drugs in the pipeline that work through similar mechanisms that should be entering the market which should lower the price through competition. Heart disease, diabetes, and fatty liver disease are some of the most common killers and the reduction in excess body fat will causally and significantly lower the risks for all of them.